Keyword: Germany

A pilot clinical study demonstrated how Kaia Health’s artificial intelligence-based smartphone app could reduce a patient’s COPD symptoms.

Implandata Ophthalmic successfully implanted a new version of its intraocular pressure sensor in its first patient in a first-in-human clinical trial.

The week’s biotech developments included a brain-penetrating compound from scorpion venom and a pact to develop virus-based cancer drugs.

Affimed has halted work on trials of its lead T cell engager AFM11 for blood cancers after a death and two life-threatening events.

Royal Philips signed two long-term consultancy deals in Germany to supply equipment and reform workflows as it transitions to a solutions provider.

Boehringer Ingelheim has unveiled a €230 million ($268 million) investment in its biologics capacity.

Researchers in Germany pinpointed why targeting Notch and MAPK signaling individually may actually exacerbate colon cancer.

Sanofi will license out a host of infectious disease assets to Evotec, with 100 staffers also moving into its R&D engine.

Magenta could pay the German biotech up to $334 million in milestones if the antibody drug conjugate pacts hit their targets.

Medigene has been given a green light in Germany to start human trials of MDG1011, the lead candidate to come out of its modified T-cell program.